Human Heredity
Original Paper
Accounting for Disease Model Uncertainty in Mapping Heterogeneous Traits – A Bayesian Model Averaging ApproachBiswas S.a · Papachristou C.baDepartment of Biostatistics, School of Public Health, University of North Texas Health Science Center, Fort Worth, Tex., and bDepartment of Mathemetics, Physics, and Statistics, University of the Sciences in Philadelphia, Philadelphia, Pa., USA
Swati Biswas, PhD Department of Biostatistics, School of Public Health University of North Texas Health Science Center 3500 Camp Bowie Blvd., Fort Worth, TX 76107-2699 (USA) Tel. +1 817 735 5442, Fax +1 817 735 2314, E-Mail swati.biswas@unthsc.edu |
|
Abstract
Background: Locus heterogeneity, wherein a disease can be caused in different individuals by different genes and/or environmental factors, is a ubiquitous feature of complex traits. A Bayesian approach has been proposed to account for variable rates of heterogeneity across families in a parametric linkage analysis setup [Biswas and Lin: J Am Stat Assoc 2006;101:1341–1351]. As with any parametric approach, its application requires specification of the disease model, which limits its practical utility. Methods: We address this limitation by proposing a Bayesian model averaging (BMA) approach. We consider a finite number of disease models and treat the model as an unknown parameter. In practice, we use simple single-locus disease models as various categories for model. Results: Our simulations as well as analysis of Genetic Analysis Workshop 13 simulated data show that BMA retains at least 80% of the power that is obtained by analyzing under the true disease model. The coverage probability of interval for disease gene is maintained around the nominal level. Finally, we apply BMA to a Late-Onset Alzheimer’s Disease dataset and find evidence for linkage on chromosomes 19, 9, and 21. Conclusion: We conclude that the BMA approach utilizing simple single-locus models for averaging is effective for mapping heterogeneous traits.
© 2010 S. Karger AG, Basel
Related Articles:
References
-
Biswas S, Lin S: A Bayesian approach for incorporating variable rates of heterogeneity in linkage analysis. J Am Stat Assoc 2006;101:1341–1351.
External Resources
- Biswas S, Lin S, Berry DA: A new Bayesian approach incorporating covariate information for heterogeneity and its comparison with HLOD. BMC Genet 2005;6:S138.
- Biswas S, Lin S: Incorporating covariates in mapping heterogeneous traits – a hierarchical model using empirical Bayes estimation. Genet Epidemiol 2007;31:684–696.
- Knapp M, Seuchter SA, Baur MP: Linkage analysis in nuclear families. II. Relationship between affected sib-pair tests and lod score analysis. Hum Hered 1994;44:44–51.
- Greenberg DA, Abreu P, Hodge SE: The power to detect linkage in complex disease by means of simple LOD-score analyses. Am J Hum Genet 1998;63:870–879.
-
Hoeting J, Madigan D, Raftery A, Volinsky C: Bayesian model averaging. Statist Sci 1999;14:382–401.
External Resources
-
Zhang L, Mukherjee B, Ghosh M, Wu R: A Bayesian framework for genetic association in case-control studies: accounting for unknown population substructure, Statist Model 2006;6:352–372.
External Resources
- Sillanpaa MJ, Corander J: Model choice in gene mapping: what and why. Trends Genet 2002;18:301–307.
- Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES: Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996;58:1347–1363.
- Gudbjartsson JE, Jonasson HH, Frigge ML, Kong A: Allegro, a new computer program for multipoint linkage analysis. Nat Genet 2000;25:12–13.
-
Almasy L, Amos CI, Bailey-Wilson JE, et al: Genetic analysis workshop 13: analysis of longitudinal family data for complex diseases and related risk factors. BMC Genet 2003;4:S1.
External Resources
- Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R: Analyses of the National Insititute on Aging Late-Onset Alzheimer’s Disease Family Study: implication of additional loci. Arch Neurol 2008;65:1518–1526.
-
Richardson S, Green PJ: On Bayesian analysis of mixtures with an unknown number of components. J Royal Stat Soc B 1997;59:731–792.
External Resources
-
Raftery AE: Hypothesis testing and model selection; in Gilks WR, Richardson S, Spiegelhalter DJ (eds): Markov Chain Monte Carlo in Practice. London, UK, Chapman & Hall, 1996, pp 163–187.
-
Thomas DC, Richardson S, Gauderman J, Pitkniemi J: A Bayesian approach to multipoint mapping in nuclear families. Genet Epidemiol 1998;14:903–908.
External Resources
- Wang Z, Lin S, Popesco M, Rotter A: Modeling and analysis of multi-library, multi-group SAGE data with application to a study of mouse cerebellum. Biometrics 2007;63:777–786.
- Daw EW, Morrison J, Zhou X, Thomas DC: Genetic analysis workshop 13: simulated longitudinal data on families for a system of oligogenic traits. BMC Genetics 2003;4 (suppl 1):S3.
- Biswas S, Papachristou C, Irwin ME, Lin S: Linkage analysis of the simulated data evaluations and comparison of methods. BMC Genet 2003;4:S70.
- Kong A, Cox N: Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997;61:1179–1188.
- Kamboh MI: Molecular genetics of late-onset Alzheimer’s disease. Ann Hum Genet 2004;68:381–404.
- Abecasis GR, Cherny SS, Cookson WO, Cardon LR: Merlin – rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002;30:97–101.
- Hayashi T, Awata T: Bayesian mapping of QTL in outbred F2 families allowing inference about whether F0 grandparents are homozygous or heterozygous at QTL. Heredity 2005;94:326–337.
- Olson JM, Goddard KAB, Dudek DM: The amyloid precursor protein locus and verylate-onset Alzheimer disease. Am J Hum Genet 2001;69:895–899.
- Scott WK, Hauser ER, Schmechel DE, Welsh-Bohmer KA, Small GW, Roses AD, Saunders AM, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA: Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22. Am J Hum Genet 2003;73:1041–1051.
- Bacanu SA, Devlin B, Chowdari KV, DeKosky ST, Nimgaonkar VL, Sweet RA: Linkage analysis of Alzheimer disease with psychosis. Neurology 2002;59:118–120.
- Wan S, Lin S: A likelihood-based procedure for obtaining confidence intervals of disease loci with general pedigree data. BMC Proc 2007;1(suppl 1):S106.
- Sillanpaa MJ, Bhattacharjee M: Association mapping of complex trait loci with contextdependent effects and unknown context variable. Genetics 2006;174:1597–1611.
- Province MA, Shannon WD, Rao DC: Classification methods for confronting heterogeneity. Adv Genet 2001;42:273–286.
- Heath SC: Markov chain Monte Carlo segregation and linkage analysis for oligogenic models. Am J Hum Genet 1997;61:748–760.
- Lee JK, Thomas DC: Performance of Markov chain-Monte Carlo approaches for mapping genes in oligogenetic models with an unknown number of loci. Am J Hum Genet 2000;67:1232–1250.
- Uimari P, Sillanpaa MJ: Bayesian oligogenic analysis of quantitative and qualitative traits in general pedigrees. Genet Epidemiol 2001;21:224–242.
-
Biswas S: On Incorporating Heterogeneity in Linkage Analysis. PhD dissertation, The Ohio State University, Department of Statistics 2003. Available at http://www.ohiolink.edu/etd/view.cgi?osu1070468056.
Article / Publication Details
Received: September 22, 2009
Accepted: January 19, 2010
Published online: March 26, 2010
Issue release date: April 2010
Number of Print Pages: 12
Number of Figures: 3
Number of Tables: 5
ISSN: 0001-5652 (Print)
eISSN: 1423-0062 (Online)
For additional information: https://www.karger.com/HHE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission